MORGAN STANLEY - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Taysha Gene Therapies, Inc. (TSHA)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Taysha Gene Therapies, Inc. Common Stock
Symbol
TSHA
Shares outstanding
205M shares
Disclosed Ownership
17.6M shares
Ownership
8.6%
Form type
SCHEDULE 13G
Date filed
2/5/2025, 10:43 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 8.6% 17.6M 0 17.4M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 7% 14.4M 0 14.4M Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC